TNFRSF4 and neoplasm: OX-40 expression on effector T cells indicates their activation status and potential for cytotoxic function against tumor cells, whereas its expression on Tregs increases their suppressive effects on anti-tumor immune responses Additionally, OX-40 expression on DCs enhances their antigen-presenting capabilities, facilitating the priming and activation of tumor-specific T cells.